92 related articles for article (PubMed ID: 23438693)
1. Mdm2 increases cellular invasiveness by binding to and stabilizing the Slug mRNA.
Jung CH; Kim J; Park JK; Hwang SG; Moon SK; Kim WJ; Um HD
Cancer Lett; 2013 Jul; 335(2):270-7. PubMed ID: 23438693
[TBL] [Abstract][Full Text] [Related]
2. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
[TBL] [Abstract][Full Text] [Related]
3. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug.
Wang SP; Wang WL; Chang YL; Wu CT; Chao YC; Kao SH; Yuan A; Lin CW; Yang SC; Chan WK; Li KC; Hong TM; Yang PC
Nat Cell Biol; 2009 Jun; 11(6):694-704. PubMed ID: 19448627
[TBL] [Abstract][Full Text] [Related]
4. Cooperative actions of p21WAF1 and p53 induce Slug protein degradation and suppress cell invasion.
Kim J; Bae S; An S; Park JK; Kim EM; Hwang SG; Kim WJ; Um HD
EMBO Rep; 2014 Oct; 15(10):1062-8. PubMed ID: 25141863
[TBL] [Abstract][Full Text] [Related]
5. Ling Zhi-8 reduces lung cancer mobility and metastasis through disruption of focal adhesion and induction of MDM2-mediated Slug degradation.
Lin TY; Hsu HY
Cancer Lett; 2016 Jun; 375(2):340-348. PubMed ID: 26992741
[TBL] [Abstract][Full Text] [Related]
6. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma.
Shih JY; Tsai MF; Chang TH; Chang YL; Yuan A; Yu CJ; Lin SB; Liou GY; Lee ML; Chen JJ; Hong TM; Yang SC; Su JL; Lee YC; Yang PC
Clin Cancer Res; 2005 Nov; 11(22):8070-8. PubMed ID: 16299238
[TBL] [Abstract][Full Text] [Related]
7. Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53.
Riscal R; Schrepfer E; Arena G; Cissé MY; Bellvert F; Heuillet M; Rambow F; Bonneil E; Sabourdy F; Vincent C; Ait-Arsa I; Levade T; Thibaut P; Marine JC; Portais JC; Sarry JE; Le Cam L; Linares LK
Mol Cell; 2016 Jun; 62(6):890-902. PubMed ID: 27264869
[TBL] [Abstract][Full Text] [Related]
8. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
Roger L; Jullien L; Gire V; Roux P
J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115
[TBL] [Abstract][Full Text] [Related]
9. The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage.
Gajjar M; Candeias MM; Malbert-Colas L; Mazars A; Fujita J; Olivares-Illana V; Fåhraeus R
Cancer Cell; 2012 Jan; 21(1):25-35. PubMed ID: 22264786
[TBL] [Abstract][Full Text] [Related]
10. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J
Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600
[TBL] [Abstract][Full Text] [Related]
11. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
12. Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities.
Yang HY; Wen YY; Lin YI; Pham L; Su CH; Yang H; Chen J; Lee MH
Oncogene; 2007 Nov; 26(52):7355-62. PubMed ID: 17546054
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of MDM2 inhibitor MI-219 against lung cancer cells alone or in combination with MDM2 knockdown, a XIAP inhibitor or etoposide.
Zheng M; Yang J; Xu X; Sebolt JT; Wang S; Sun Y
Anticancer Res; 2010 Sep; 30(9):3321-31. PubMed ID: 20944104
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional repressor snail and progression of human hepatocellular carcinoma.
Sugimachi K; Tanaka S; Kameyama T; Taguchi K; Aishima S; Shimada M; Sugimachi K; Tsuneyoshi M
Clin Cancer Res; 2003 Jul; 9(7):2657-64. PubMed ID: 12855644
[TBL] [Abstract][Full Text] [Related]
15. P53 mRNA controls p53 activity by managing Mdm2 functions.
Candeias MM; Malbert-Colas L; Powell DJ; Daskalogianni C; Maslon MM; Naski N; Bourougaa K; Calvo F; Fåhraeus R
Nat Cell Biol; 2008 Sep; 10(9):1098-105. PubMed ID: 19160491
[TBL] [Abstract][Full Text] [Related]
16. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer.
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Histopathology; 2014 Mar; 64(4):523-35. PubMed ID: 24289472
[TBL] [Abstract][Full Text] [Related]
18. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer.
Brighenti E; Calabrese C; Liguori G; Giannone FA; Trerè D; Montanaro L; Derenzini M
Oncogene; 2014 Aug; 33(35):4396-406. PubMed ID: 24531714
[TBL] [Abstract][Full Text] [Related]
20. MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation.
Yang JY; Zong CS; Xia W; Wei Y; Ali-Seyed M; Li Z; Broglio K; Berry DA; Hung MC
Mol Cell Biol; 2006 Oct; 26(19):7269-82. PubMed ID: 16980628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]